Lantheus Holdings announced plans to acquire Evergreen Theragnostics in an all-cash deal valued at $250 million.

#LantheusHoldings #EvergreenTheragnostics #acquisition #diagnosticscompany #radiopharmaceutical #CDMO #pharmanews #pharmamanufacturing
#LantheusHoldings #EvergreenTheragnostics #acquisition #diagnosticscompany #radiopharmaceutical #CDMO #pharmanews #pharmamanufacturing